Sichuan Kelun Pharmaceutical Co Ltd

Research Sichuan Kelun Pharmaceutical Co Ltd (002422.SZ) on Bullrun: market cap CNY 63.55B, P/E 34.1, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 63.55B; P/E is 34.1; dividend yield is 1.1%.

Peer valuation comparison

Latest P/E is 34.15x versus a Healthcare sector median of 21.69x (57.4% above).

Latest dividend yield is 1.08% versus a Healthcare sector median of 2.41% (55.2% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 63.55B34.11.5%0.59

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.59 CNY, yield 1.1%.

About Sichuan Kelun Pharmaceutical Co Ltd

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Modern Chinese Medicine Group Co., Ltd. (1643.HK) Tong Ren Tang Technologies Co. Ltd. (1666.HK) Vigonvita Life Sciences Co., Ltd. (2630.HK) Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436.SS) IMPACT Therapeutics, Inc (7630.HK) Alebund Pharmaceuticals (Jiangsu) Limited (9637.HK) Shandong Dong-Ee Jiao Co Ltd (000423.SZ) Livzon Pharmaceutical Group Inc (000513.SZ) Yunnan Baiyao Group Co., Ltd. (000538.SZ) Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) Chang Chun High and New Technology Industry (Group) Inc. (000661.SZ) Apeloa Pharmaceutical Co., Ltd. (000739.SZ)

Frequently asked questions

What is Sichuan Kelun Pharmaceutical Co Ltd's market cap?

Sichuan Kelun Pharmaceutical Co Ltd's market capitalization is CNY 63.55B.

What is Sichuan Kelun Pharmaceutical Co Ltd's P/E ratio?

Sichuan Kelun Pharmaceutical Co Ltd's price-to-earnings (P/E) ratio is 34.1.

Does Sichuan Kelun Pharmaceutical Co Ltd pay a dividend?

Sichuan Kelun Pharmaceutical Co Ltd has a dividend yield of 1.1%.

What does Sichuan Kelun Pharmaceutical Co Ltd do?

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments.